ACE2 Receptor and Antibody Binding to SARS-CoV‑2 Spikes and Virions by Single-Molecule Fluorescence

ACE2 Receptor and Antibody Binding to SARS-CoV‑2 Spikes and Virions by Single-Molecule Fluorescence

Saved in:

Bibliographic Details
Main Authors:	Souradip Dasgupta, Srijan Ray, Aswin T. Srivatsav, Anthony L. DeVico, Krishanu Ray
Format:	Article
Language:	English
Published:	American Chemical Society 2025-07-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.5c03887
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Disrupting SARS-CoV-2 Spike–ACE2 Interactions via Glycosaminoglycans in a Pseudoviral Study of Heparan Sulfate and Enoxaparin
by: Virginia Fuochi, et al.
Published: (2025-06-01)

SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19
by: Huai‐Chia Chuang, et al.
Published: (2022-07-01)

Interfacial subregions of SARS-CoV-2 spike RBD to hACE2 affect intermolecular affinity by their distinct roles played in association and dissociation kinetics
by: Xiangwu Tang, et al.
Published: (2024-12-01)

Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
by: Vanessa Monteil, et al.
Published: (2020-12-01)

Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants
by: Vanessa Monteil, et al.
Published: (2022-07-01)

Corrigendum to “Favipiravir vs. Deferiprone: tautomeric, photophysical, in vitro biological studies, and binding interactions with SARS-Cov-2-MPro/ACE2” [Curr. Res. Biotechnol. 7 (2024) 100176]
by: Nikolay T. Tzvetkov, et al.
Published: (2025-01-01)

Age-dependent ACE2/TMPRSS2 expression and SARS-CoV-2 household transmission in Gran Canaria.
by: Jesús Poch-Páez, et al.
Published: (2025-01-01)

The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2.
by: Jamie Guenthoer, et al.
Published: (2024-08-01)

Dual inhibition of ACE-2 and TMPRSS2: A promising strategy to mitigate SARS-CoV-2 severity in smokers
by: Kingshuk Panda, et al.
Published: (2025-09-01)

Virion motility of sialoglycan-cleaving respiratory viruses
by: Mengying Liu, et al.
Published: (2025-07-01)

Binding memory of liquid molecules
by: Shiyi Qin, et al.
Published: (2025-07-01)

ASCT2 inhibits HIV-1 infectivity by promoting the incorporation of a gp160/ASCT2 complex into virions
by: Luciana Morellatto Ruggieri, et al.
Published: (2025-08-01)

Analysis of the docking property of host variants of hACE2 for SARS-CoV-2 in a large cohort.
by: Hyojung Paik, et al.
Published: (2022-07-01)

SARS-CoV-2 Spike Protein and Long COVID—Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome
by: Bruno Pereira de Melo, et al.
Published: (2025-04-01)

Inactivation of SARS-CoV-2 at acidic pH is driven by partial unfolding of spike
by: Irina Glas, et al.
Published: (2025-07-01)

Evolution of the SARS-CoV-2 spike protein in utilizing host transmembrane serine proteases
by: Aleksandra Milewska, et al.
Published: (2025-09-01)

Characterization of private mutations in the spike protein of SARS-CoV-2 correlates with viral prevalence
by: Shuo Wang, et al.
Published: (2025-08-01)

Conformational and Stability Analysis of SARS-CoV-2 Spike Protein Variants by Molecular Simulation
by: Gustavo E. Olivos-Ramirez, et al.
Published: (2025-03-01)

Molecular Insights into the Interaction between CD147 and the SARS-CoV‑2 Spike Protein
by: Milton S. Gonzalez-Serrano, et al.
Published: (2025-08-01)

SARS‐CoV‐2 spike spurs intestinal inflammation via VEGF production in enterocytes
by: Fa‐Min Zeng, et al.
Published: (2022-04-01)

TIPE2 suppresses ferroptosis and pro-inflammatory polarization in macrophages triggered by SARS-CoV-2 spike protein
by: Simin Zhu, et al.
Published: (2025-08-01)

A Novel Antiviral Therapeutic Platform: Anchoring IFN-β to the Surface of Infectious Virions Equips Interferon-Evasive Virions with Potent Antiviral Activity
by: Hoda H. Jabbour, et al.
Published: (2025-05-01)

Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers
by: Javier Martínez-Sanz, et al.
Published: (2021-01-01)

An spike-accum® bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity
by: Jean Pierre Bikorimana, et al.
Published: (2025-09-01)

Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS-CoV-2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28)
by: I. O. Stoma, et al.
Published: (2024-07-01)

Identification of SARS-CoV-2-binding lectins on a commercial lectin array
by: Neetu, et al.
Published: (2025-07-01)

Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS‐CoV‐2 spike protein
by: Lydia Horndler, et al.
Published: (2021-02-01)

Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein
by: Kentarou Waki, et al.
Published: (2025-05-01)

ADME analysis, metabolic prediction, and molecular docking of lipoic acid with SARS-CoV-2 Omicron spike protein
by: Carlos Alonso Leite dos Santos, et al.
Published: (2025-07-01)

SARS-CoV-2 Infection after Effects: Multi-Organ Damage through Oxygen Radicals
by: Debatosh Datta, et al.
Published: (2022-01-01)

Development of Novel ssDNA Aptamers for Detection of Receptor-Binding Domain of SARS-COV‑2
by: Amogh Auti, et al.
Published: (2025-06-01)

RETRACTED: Role of Protein VII in the Production of Infectious Bovine Adenovirus-3 Virion
by: Shermila Kulanayake, et al.
Published: (2024-08-01)

Estimated COVID-19 Periodicity and Correlation with SARS-CoV-2 Spike Protein S1 Antigenic Diversity, United States
by: Erica Billig Rose, et al.
Published: (2025-08-01)

Epitope mapping of SARS-CoV-2 Spike protein using naturally-acquired immune responses to develop monoclonal antibodies
by: Rubén López-Aladid, et al.
Published: (2025-05-01)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
by: Abdullah G. Al-Sehemi, et al.
Published: (2022-05-01)

Enhancement of SARS-CoV-2 Receptor Binding Domain -CR3022 Human Antibody Binding Affinity via In silico Engineering Approach
by: Fatemeh Sefid, et al.
Published: (2021-09-01)

Global analysis of small molecule binding to related protein targets.
by: Felix A Kruger, et al.
Published: (2012-01-01)

Escherichia coli Nissle 1917 efficiently expresses the RBD domain of SARS-CoV-2 spike protein without codon optimization
by: Shanmugaraja Meenakshi, et al.
Published: (2025-05-01)

Comprehensive N-glycosylation profiling of recombinant spike S1 protein from the wild-type SARS-CoV-2 and its variants
by: Yao Peng, et al.
Published: (2025-07-01)

Dual‐Locking the SARS‐CoV‐2 Spike Trimer: An Amphipathic Molecular “Bolt” Stabilizes Conserved Druggable Interfaces for Coronavirus Inhibition
by: Shiliang Li, et al.
Published: (2025-07-01)